Table 2. Univariable logistic regression analysis for urinary incontinence, hematuria and pain during voiding.
Only p-values < 0.05 are shown.
Odds ratio (OR)* | CI | p-Value | ||
---|---|---|---|---|
Urinary Incontinence ≥ grade 2 (n = 20) | ||||
Trigone | Mean dose | 1.11 | 1.02–1.20 | 0.015 |
V55 | 1.08 | 1.01–1.16 | 0.027 | |
V60 | 1.06 | 1.01–1.11 | 0.016 | |
V65 | 1.05 | 1.01–1.08 | 0.010 | |
V70 | 1.03 | 1.01–1.05 | 0.008 | |
V75 | 1.01 | 1.00–1.02 | 0.042 | |
Hematuria ≥1 (n = 23) | ||||
Cardiovascular disease | 2.845 | 1.19–6.80 | 0.019 | |
Anticoagulants use | 2.424 | 1.01–5.85 | 0.049 | |
Bladderwall | Mean dose | 1.028 | 1.00–1.06 | 0.032 |
V40 | 1.017 | 1.00–1.03 | 0.040 | |
V45 | 1.019 | 1.00–1.04 | 0.024 | |
V50 | 1.020 | 1.00–1.04 | 0.015 | |
V55 | 1.021 | 1.00–1.04 | 0.014 | |
V60 | 1.022 | 1.01–1.04 | 0.011 | |
V65 | 1.024 | 1.01–1.04 | 0.007 | |
V70 | 1.026 | 1.01–1.04 | 0.004 | |
V75 | 1.027 | 1.01–1.04 | 0.002 | |
Bladder | V70 | 1.015 | 1.00–1.03 | 0.029 |
V75 | 1.015 | 1.00–1.03 | 0.021 | |
Pain during voiding | ||||
TURP | 2.46 | 1.01–5.99 | 0.048 | |
Trigone | Mean dose | 1.106 | 1.03–1.19 | 0.008 |
V50 | 1.048 | 1.00–1.10 | 0.043 | |
V55 | 1.047 | 1.01–1.09 | 0.024 | |
V60 | 1.042 | 1.01–1.08 | 0.015 | |
V65 | 1.038 | 1.01–1.07 | 0.008 | |
V70 | 1.030 | 1.01–1.05 | 0.003 | |
V75 | 1.021 | 1.01–1.03 | 0.001 |
For dose variables OR: increase per 1 Gy increase in dose, for volume parameters: increase per 1% increase in volume
TURP: transurethral resection of the prostate